Compounds > bupranolol

bupranolol and sq-11725

bupranolol has been researched along with sq-11725 in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H1
Amend, A; Candelore, MR; Cascieri, MA; Deng, L; Guan, XM; Liu, Y; Newbold, R; Tota, L; Weber, AE1
Baker, JG1
Atef, N; Doublé, A; Hélary, C; Ktorza, A; Lafontan, M; Pénicaud, L1
Horinouchi, T; Koike, K1
Balligand, JL; Donckier, JE; Gauthier, C; Heyndrickx, GR; Massart, PE; Van Mechelen, H1
Erfanian, M; Gauthier, C; Heymann, MF; Langin, D; Laurent, K; Tavernier, G; Toumaniantz, G1
Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P1
Boccioletti, V; Cominacini, L; Evangelista, S; Garbin, U; Pasini, AF; Stranieri, C1

Reviews

1 review(s) available for bupranolol and sq-11725

ArticleYear
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:11

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship

1988

Other Studies

8 other study(ies) available for bupranolol and sq-11725

ArticleYear
Potent and selective human beta(3)-adrenergic receptor antagonists.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:2

    Topics: Adipocytes; Adrenergic beta-Antagonists; Aminophenols; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Ligands; Lipolysis; Macaca mulatta; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Sulfonamides

1999
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    British journal of pharmacology, 2005, Volume: 144, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3

2005
A specific beta 3-adrenoceptor agonist induces increased pancreatic islet blood flow and insulin secretion in rats.
    European journal of pharmacology, 1996, Mar-18, Volume: 298, Issue:3

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Female; Insulin; Insulin Secretion; Islets of Langerhans; Nadolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow

1996
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
    European journal of pharmacology, 2001, Mar-23, Volume: 416, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism

2001
Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
    European journal of clinical investigation, 2001, Volume: 31, Issue:8

    Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Aorta; Atropine Derivatives; Blood Pressure; Bupranolol; Dogs; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hexamethonium; Hypertension, Renal; Lipolysis; Myocardial Contraction; Nadolol; Propanolamines; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes; Time Factors

2001
beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor.
    Cardiovascular research, 2003, Aug-01, Volume: 59, Issue:2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blotting, Western; Bupranolol; Cyclic GMP; Depression, Chemical; Dioxoles; Electrocardiography; Humans; Mice; Mice, Transgenic; Models, Animal; Myocardial Contraction; Myocardium; Nadolol; Receptors, Adrenergic, beta-3; Tetrahydronaphthalenes

2003
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Circulation, 2004, Aug-24, Volume: 110, Issue:8

    Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation

2004
Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.
    Pharmacological research, 2007, Volume: 55, Issue:4

    Topics: Adrenergic beta-Antagonists; Antioxidants; Benzopyrans; Biotransformation; Bupranolol; Calcium; Cells, Cultured; Endothelial Cells; Enzyme Activation; Ethanolamines; Humans; Lipoproteins, LDL; Nadolol; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Propanolamines; Receptors, Adrenergic, beta; Stereoisomerism; Superoxides

2007